Skip to main navigation
Skip to main content
Skip to Footer
English
Čeština
Czech republic
Novartis Site Directory
Our Work
Product Portfolio
Research and Development
Clinical Research in Novartis Czech Republic
About Us
Our Mission and Vision
Our Values
Novartis in the Czech Republic
Our People
Social Responsibility in the Czech Republic
Contact us
Privacy policy
VPOIS
VPOIS
News
News Archive
Featured News
Media Releases
Stories
Media Contacts
Careers
Careers Search
Working at Novartis Czech Republic
Employee Benefits
Employee Development
Awards & Recognition
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Stories
Filter By
2015
October
Media Release
/
Oct 02, 2015
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept
Read More
September
Media Release
/
Sep 30, 2015
Novartis announces NEJM publication of secukinumab Phase III data confirming significant efficacy in patients with psoriatic arthritis
Read More
Media Release
/
Sep 28, 2015
Patients with aggressive form of melanoma lived for more than two years on average when taking Novartis therapies Tafinlar® + Mekinist®
Read More
Media Release
/
Sep 27, 2015
Novartis drug Afinitor® significantly improves progression-free survival in advanced nonfunctional gastrointestinal and lung NET
Read More
Media Release
/
Sep 25, 2015
Novartis' new heart failure medicine Entresto(TM) recommended by CHMP for EU approval
Read More
Media Release
/
Sep 24, 2015
Read More
Media Release
/
Sep 24, 2015
Read More
Media Release
/
Sep 24, 2015
Novartis appoints James E. Bradner, MD as President of the Novartis Institutes for BioMedical Research as Mark Fishman retires
Read More
Media Release
/
Sep 24, 2015
Read More
Media Release
/
Sep 24, 2015
Read More
Pages
1
2
3
4
5
…
next ›
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
Pinterest
LinkedIn
Google +
Email
Jump to Comments
Print
You are here
Home
›
News
